Kits Eyecare (TSE:KITS) has released an update.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Kits Eyecare Ltd. has successfully completed a secondary offering of common shares, resulting in the sale of over 1.1 million shares owned by key stakeholders, including Roger Hardy, at $10.15 per share. The offering, which did not financially benefit KITS directly, was facilitated by Canaccord Genuity and Beacon Securities. Alongside the offering, a concurrent sale of shares by the spouse of Sabrina Liak was also completed, with insiders continuing to hold approximately 75% of the company’s shares.
For further insights into TSE:KITS stock, check out TipRanks’ Stock Analysis page.

